{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:12:48Z","timestamp":1793747568186,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01BX00357"],"award-info":[{"award-number":["1I01BX00357"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY017294"],"award-info":[{"award-number":["R01EY017294"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY030774"],"award-info":[{"award-number":["R01EY030774"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01EY031650"],"award-info":[{"award-number":["U01EY031650"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.exer.2021.108610","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T11:19:52Z","timestamp":1619781592000},"page":"108610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["The functional role of decorin in corneal neovascularization in vivo"],"prefix":"10.1016","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8365-9991","authenticated-orcid":false,"given":"Praveen K.","family":"Balne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneel","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bristow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5965-5341","authenticated-orcid":false,"given":"Matthew","family":"Faubion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9877-3017","authenticated-orcid":false,"given":"Sally D.","family":"Heil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant R.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney L.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato V.","family":"Iozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv R.","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2021.108610_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/cells8050471","article-title":"Role of angiopoietin-2 in vascular physiology and pathophysiology","volume":"8","author":"Akwii","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.exer.2021.108610_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0945-053X(03)00018-0","article-title":"Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts","volume":"22","author":"Al Haj Zen","year":"2003","journal-title":"Matrix Biol."},{"key":"10.1016\/j.exer.2021.108610_bib3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/ICO.0b013e3181605ff9","article-title":"Inhibition of experimental angiogenesis of cornea by various doses of doxycycline and combination of triamcinolone acetonide with low-molecular-weight heparin and doxycycline","volume":"27","author":"Aydin","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2021.108610_bib4","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.exer.2021.108610_bib5","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","article-title":"Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis","volume":"117","author":"Bachmann","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2021.108610_bib6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2353\/ajpath.2009.090206","article-title":"Angiogenesis in platelet endothelial cell adhesion molecule-1-null mice","volume":"175","author":"Cao","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2021.108610_bib7","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00417-011-1709-6","article-title":"Combination of vascular endothelial growth factor receptor\/platelet-derived growth factor receptor inhibition markedly improves the antiangiogenic efficacy for advanced stage mouse corneal neovascularization","volume":"249","author":"Chaoran","year":"2011","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108610_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1083\/jcb.136.3.729","article-title":"Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility","volume":"136","author":"Danielson","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.exer.2021.108610_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00417-014-2851-8","article-title":"Three-year corneal graft survival rate in highrisk cases treated with subconjunctival and topical bevacizumab","volume":"253","author":"Dekaris","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108610_bib10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bjophthalmol-2011-300856","article-title":"Evaluation of corneal neovascularisation","volume":"95","author":"Faraj","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108610_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.matbio.2016.09.009","article-title":"Decorin interacting network: a comprehensive analysis of decorin-binding partners and their versatile functions","volume":"55","author":"Gubbiotti","year":"2016","journal-title":"Matrix Biol."},{"key":"10.1016\/j.exer.2021.108610_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.matbio.2015.01.023","article-title":"Pivotal role for decorin in angiogenesis","volume":"43","author":"J\u00e4rvel\u00e4inen","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.exer.2021.108610_bib14","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1167\/iovs.08-2805","article-title":"Bevacizumab application delays epithelial healing in rabbit cornea","volume":"50","author":"Kim","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108610_bib15","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/ceo.12085","article-title":"Bevacizumab eye drops delay corneal epithelial wound healing and increase the stromal response to epithelial injury in rats","volume":"41","author":"Kim","year":"2013","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108610_bib16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/ICO.0b013e3182781ea4","article-title":"The role of Nod1 signaling in corneal neovascularization","volume":"32","author":"Kim","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2021.108610_bib17","first-page":"2964","article-title":"Therapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface","volume":"2010; 16","author":"Kitano","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2021.108610_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108610_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08820530902801478","article-title":"Limbal stem cell deficiency and corneal neovascularization","volume":"24","author":"Lim","year":"2009","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108610_bib20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/cbdd.13018","article-title":"Recent drug therapies for corneal neovascularization","volume":"90","author":"Liu","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.exer.2021.108610_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.exer.2021.108610_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000226222","article-title":"MT1-MMP-mediated cleavage of decorin in corneal angiogenesis","volume":"46","author":"Mimura","year":"2009","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.exer.2021.108610_bib23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.exer.2007.10.014","article-title":"A novel method for generating corneal haze in anterior stroma of the mouse eye with the excimer laser","volume":"86","author":"Mohan","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108610_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026432","article-title":"Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo","volume":"6","author":"Mohan","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2021.108610_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/156652411794859241","article-title":"Decorin biology, expression, function and therapy in the cornea","volume":"11","author":"Mohan","year":"2011","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.exer.2021.108610_bib26","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1167\/iovs.11-7357","article-title":"Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy","volume":"52","author":"Mohan","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108610_bib27","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1074\/jbc.M111.283499","article-title":"Decorin Antagonizes the Angiogenic Network. Concurrent inhibition of Met, hypoxia inducible factor-1\u03b1 and vascular endothelial growth factor A and induction of thrombospondin-1 and TIMP3","volume":"287","author":"Neill","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2021.108610_bib28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9440(10)63447-5","article-title":"Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty","volume":"163","author":"Nili","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2021.108610_bib29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1096\/fj.04-2209fje","article-title":"Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive","volume":"19","author":"Oshima","year":"2005","journal-title":"Faseb. J."},{"key":"10.1016\/j.exer.2021.108610_bib30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/ICO.0b013e3182542613","article-title":"Vascular endothelial growth factor inhibitors for treatment of corneal neovascularization: a metaanalysis","volume":"2013; 32","author":"Papathanassiou","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2021.108610_bib31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bjophthalmol-2012-302137","article-title":"Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial","volume":"97","author":"Petsoglou","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108610_bib32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","article-title":"Current and emerging therapies for corneal neovascularization","volume":"16","author":"Roshandel","year":"2018","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2021.108610_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/cr.1998.17","article-title":"Complex role of matrix metalloproteinases in angiogenesis","volume":"8","author":"Sang","year":"1998","journal-title":"Cell Res."},{"key":"10.1016\/j.exer.2021.108610_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.exer.2021.108610_bib35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000081806","article-title":"Decorin deficiency leads to impaired angiogenesis in injured mouse cornea","volume":"41","author":"Sch\u00f6nherr","year":"2004","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.exer.2021.108610_bib36","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3109\/02713683.2010.502294","article-title":"Expression of MMP, HPSE, and FAP in stroma promoted corneal neovascularization induced by different etiological factors","volume":"35","author":"Shi","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2021.108610_bib37","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1096\/fj.201700867RR","article-title":"Endoglin interacts with VEGFR2 to promote angiogenesis","volume":"32","author":"Tian","year":"2018","journal-title":"Faseb. J."},{"key":"10.1016\/j.exer.2021.108610_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107705","article-title":"Is sex a biological variable in corneal wound healing?","volume":"187","author":"Tripathi","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108610_bib39","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1600-0420.1997.tb00623.x","article-title":"Vascular endothelial growth factor (VEGF) in normal human corneal epithelium: detection and physiological importance","volume":"75","author":"Van Setten","year":"1997","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.exer.2021.108610_bib40","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/ATVBAHA.114.304627","article-title":"Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization","volume":"35","author":"Wang","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.exer.2021.108610_bib41","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/1535-7163.MCT-06-0689","article-title":"Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo","volume":"6","author":"Yin","year":"2007","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.exer.2021.108610_bib42","doi-asserted-by":"crossref","first-page":"8888","DOI":"10.1074\/jbc.M806590200","article-title":"Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan","volume":"284","author":"Zhang","year":"2009","journal-title":"J. Biol. Chem."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521001767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521001767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:14:04Z","timestamp":1757999644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483521001767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":41,"alternative-id":["S0014483521001767"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2021.108610","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The functional role of decorin in corneal neovascularization in vivo","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2021.108610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108610"}}